Log in to save to my catalogue

DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential...

DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3405a6cd82e746178eca30e198d89dbb

DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential biomarker for sarcopenia

About this item

Full title

DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential biomarker for sarcopenia

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of Cachexia, Sarcopenia and Muscle, 2024-06, Vol.15 (3), p.1209-1217

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Sarcopenia is characterized by progressive loss of muscle mass and function due to aging. DNA methylation has been identified to play important roles in the dysfunction of skeletal muscle. The aim of our present study was to explore the whole blood sample‐based methylation changes of skeletal muscle function‐related factors in patient...

Alternative Titles

Full title

DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential biomarker for sarcopenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3405a6cd82e746178eca30e198d89dbb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3405a6cd82e746178eca30e198d89dbb

Other Identifiers

ISSN

2190-5991,2190-6009

E-ISSN

2190-6009

DOI

10.1002/jcsm.13472

How to access this item